)
Intellia Therapeutics (NTLA) investor relations material
Intellia Therapeutics Proxy filing summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.Voting matters and shareholder proposals
Election of three class I directors to serve until the 2029 annual meeting, with nominees Muna Bhanji, Brian Goff, and Jesse Goodman recommended for election.
Ratification of Deloitte & Touche LLP as independent registered public accounting firm for the fiscal year ending December 31, 2026.
Advisory vote to approve the compensation of named executive officers.
Provision for transaction of any other business properly brought before the meeting or its adjournment.
Board of directors and corporate governance
Board recommends all three director nominees for election to serve three-year terms until 2029.
Executive compensation and say-on-pay
Shareholders are asked to approve, on a non-binding advisory basis, the compensation of named executive officers.
- Proxy covers director elections, auditor ratification, pay, and strong governance and ESG focus.NTLA
Proxy filing30 Apr 2026 - Lonvo-z achieved 87% attack reduction and 62% attack-free rates in Phase 3 HAELO trial.NTLA
Study result28 Apr 2026 - Mid-year data from a pivotal HAE study could enable a first-in-class gene editing launch next year.NTLA
Leerink Global Healthcare Conference 20269 Mar 2026 - lonvo-z Phase III results expected mid-2026, with U.S. launch and high-margin revenue targeted for 2027.NTLA
TD Cowen 46th Annual Health Care Conference3 Mar 2026 - Strong clinical progress and improved financials support key launches and operations into 2027.NTLA
Q4 202526 Feb 2026 - Pivotal trials advanced, $940M cash runway, and $147M Q2 net loss amid sector risks.NTLA
Q2 20242 Feb 2026 - All shareholder proposals, including director elections and governance amendments, were approved.NTLA
AGM 20241 Feb 2026 - NTLA-2002 achieved 98% HAE attack reduction and durable efficacy, with most patients attack-free.NTLA
Study Update31 Jan 2026 - Up to 81% attack reduction and 73% attack-free rate after a single 50 mg dose.NTLA
Study Update18 Jan 2026
Next Intellia Therapeutics earnings date
Next Intellia Therapeutics earnings date
The essential earnings season companion
The #1 app for qualitative research. Live earnings calls, AI chat, transcripts, and more. All for free.
Live calls and transcripts
Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.
Find what you need faster
Search for any keyword across all transcripts simultaneously.
Easily store key findings
Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Your watchlist. Your dashboard.
Follow the companies that matter to you. Get a personalized feed with real-time updates.
Be the first to know
Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.
Consensus estimates
Access analyst consensus estimates, valuation multiples, and revenue segments splits.
All IR material in one place
The easiest way to stay updated during earnings season.
Global coverage
All events from public companies. Live and recorded.
Just click and listen
No webcast links. No manual registrations.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
I can't remember the last time an app had such a positive impact on my investment process.
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
I can't remember the last time an app had such a positive impact on my investment process.
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
Frequently asked questions
Explore our global coverage
)
)